Improved Outcomes In Ptcl With The Use Of Novel Agents And Transplantation

Improved outcomes in PTCL with the use of novel agents and transplantation

VJHemOnc – Video Journal of Hematology & HemOnc

Novel agent therapies are improving R/R PTCL outcomes

VJHemOnc – Video Journal of Hematology & HemOnc

Optimizing frontline treatment for PTCL: introducing novel agents into CHOP-based regimens

VJHemOnc – Video Journal of Hematology & HemOnc

Progress in Developing Novel Treatment Options for PTCL

PeerView Oncology

Novel Agents and Chemotherapy Regimens in PTCL

Improving patient outcomes in CTCL: clinical collaboration and novel agents

VJHemOnc – Video Journal of Hematology & HemOnc

The need for novel agents for the treatment of PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

T-cell Lymphoma

Peripheral T-Cell Lymphoma: What is New on the Horizon?

Update on Peripheral T-Cell Lymphoma Webinar | LRF Webinars

Lymphoma Research Foundation

Insights into the treatment of peripheral T-cell lymphomas and the role of autologous transplant

VJHemOnc – Video Journal of Hematology & HemOnc

Tatyana Feldman, MD, shares outcomes of the ECHELON-2 study in PTCL

New Targets in peripheral T cell lymphomas

The Current Unmet Needs in PTCL Treatment and Prospects

How can we improve our therapy for T-cell lymphoma? Should certain therapeutic options be upfront?

Major unmet needs in PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

The current standard of care for patients with PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

Long-term outcomes for patients with PTCL: 10-year follow-up analysis

VJHemOnc – Video Journal of Hematology & HemOnc

Novel therapeutic regimens being explored in PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

Jasmine Zain, MD, elaborates on the investigation of novel induction regimens in PTCL